Dow Up0.30% Nasdaq Up0.45%

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS
41.21 Up 1.71(4.33%) 3:32PM EDT - Nasdaq Real Time Price
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.5
Mean Recommendation (last week):2.5
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:45.50
Median Target:52.50
High Target:70.00
Low Target:10.00
No. of Brokers:10

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Oct 17, 2012Summer Street ResearchDowngradeBuyNeutral
May 22, 2012NeedhamInitiated Buy
Mar 26, 2012Canaccord GenuityInitiated Hold
Aug 5, 2010MP AdvisorsDowngradeOutperformMarket Perform
Aug 5, 2010Collins StewartDowngradeBuyHold
Apr 6, 2010Auriga U.S.AInitiated Hold
Jul 29, 2009Cantor FitzgeraldInitiated Buy
Feb 10, 2009CitigroupInitiated Hold
Jan 9, 2009Morgan JosephInitiated Buy
Dec 16, 2008Collins StewartInitiated Buy

More Upgrades & Downgrades for ISIS

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy1111
Buy6555
Hold3344
Underperform0000
Sell1111

Data provided by Thomson/First Call


Currency in USD.